Andrea Necchi, Head of Genitourinary Medical Oncology at Ospedale San Raffaele, shared on LinkedIn:
“Real-world overall survival improvements in metastatic urothelial carcinoma across three key therapeutic temporal periods:
platinum-based chemo vs IO vs IO and ADCs.”
Title: Real-world overall survival improvements in metastatic urothelial carcinoma across three key therapeutic temporal periods
Authors: A. Cigliola, B.A. Maiorano, G. Guandalini, V. Tateo, C. Mercinelli, M. Piacentini, A. Bertini, N. Dizman, S.K. Pal, S. Gupta, P. Grivas, A. Kamat, P.E. Spiess, N. Agarwal, A. Briganti, F. Montorsi, and A. Necchi.
Andrea Necchi was recognized among OncoDaily’s The 100 Most Influential People in Oncology in 2025, highlighting his contributions to the field of oncology.
Nominations for 100 Influential People in Oncology 2026 are now open, recognizing leaders, researchers, clinicians, innovators, advocates, and other individuals making a meaningful impact on oncology and cancer care.
Don’t miss the opportunity to nominate yourself, a colleague, or someone whose contributions deserve to be recognized.
Submit your nomination by September 15: 100 Influential People in Oncology 2026 – Nominations are Open!
Other articles about MUC on OncoDaily.
